These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 15449444)
1. [Morphometric and histological evaluation of uterine leiomyomas treated with GnRH agonists or progestational agents]. Resta L; Sanguedolce F; Orsini G; Laricchia L; Piscitelli D; Fiore MG Pathologica; 2004 Apr; 96(2):35-41. PubMed ID: 15449444 [TBL] [Abstract][Full Text] [Related]
2. Morphometric and electron-microscopic analyses of the effects of gonadotropin-releasing hormone agonists on uterine leiomyomas. Kalir T; Goldstein M; Dottino P; Brodman M; Gordon R; Deligdisch L; Wu H; Gil J Arch Pathol Lab Med; 1998 May; 122(5):442-6. PubMed ID: 9593346 [TBL] [Abstract][Full Text] [Related]
3. Pathological evaluation of uterine leiomyomas treated with gonadotropin-releasing hormone agonist (GnRH-a) therapy: role of mast cells and a possible mechanism of GnRH-a resistance in leiomyomas. Nakayama M; Mitsuhashi T; Shimizu Y; Ishihara O; Shimizu M Pathol Int; 2008 May; 58(5):268-74. PubMed ID: 18429824 [TBL] [Abstract][Full Text] [Related]
4. Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas. Saltiel E Formulary; 1995 Sep; 30(9):532-4, 542. PubMed ID: 10161243 [TBL] [Abstract][Full Text] [Related]
5. GnRH agonists before surgery for uterine leiomyomas. A review. Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917 [TBL] [Abstract][Full Text] [Related]
6. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas. Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890 [TBL] [Abstract][Full Text] [Related]
11. Effects of gonadotropin-releasing hormone agonists on uterine leiomyomas. Cramer SF Arch Pathol Lab Med; 1998 Dec; 122(12):1045-6. PubMed ID: 9870847 [No Abstract] [Full Text] [Related]
12. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas. Wang PH; Lee WL; Cheng MH; Yen MS; Chao KC; Chao HT Taiwan J Obstet Gynecol; 2009 Jun; 48(2):133-7. PubMed ID: 19574174 [TBL] [Abstract][Full Text] [Related]
15. [A comparative efficacy study of the preoperative use of GnRH agonists in women with uterine fibromyomas]. Nikolov A; Karag'ozov I Akush Ginekol (Sofiia); 1999; 38(4):38-42. PubMed ID: 10726353 [TBL] [Abstract][Full Text] [Related]
16. [Pulmonary densities following a hysterectomy, caused by benign metastatic leiomyoma]. Scheer ML; Slebos DJ; Bogchelman DH; Timens W Ned Tijdschr Geneeskd; 2008 Sep; 152(37):2027-31. PubMed ID: 18825892 [TBL] [Abstract][Full Text] [Related]
17. The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues. Colgan TJ; Pendergast S; LeBlanc M Hum Pathol; 1993 Oct; 24(10):1073-7. PubMed ID: 8406417 [TBL] [Abstract][Full Text] [Related]